Social Innovation Lab, Founders’ Scholarship, and MediEd - New Additions to Medidata’s Corporate Social Responsibility Programs
NEW YORK, NY – December 4, 2019 – Medidata, the global leader in creating end-to-end solutions supporting the entire clinical trial process, and a Dassault Systèmes company, announced three new social impact initiatives within its expanding corporate social responsibility (CSR) program: Social Innovation Lab, Founders’ Scholarship, and MediEd. These programs are designed to make a difference in the lives of patients and researchers and are part of Medidata’s mission to power smarter treatments and healthier people.
Social Innovation Lab: Medidata employee volunteers participate in cross-functional teams to support non-profit partners with programs that expand patient access to treatment. These efforts include:
“The collaboration with Medidata is a game changer for us, vastly expanding the limited resources of Lazarex to complete research projects that are well beyond the scope of what we can accomplish on our own,” said Dana Dornsife, founder and board chair, Lazarex. “The Medidata results are vital for us to make evidence-based decisions, elevating us from trial and error efforts to taking strategic and precise program actions.”
Founders’ Scholarship: In honor of Medidata’s 20th Anniversary, the Founders Scholarship program will provide a $20,000 scholarship in support of a junior or senior college student pursuing a STEM education. The recipient will also receive an internship at Medidata’s headquarters in New York City during the summer of 2020. Scholarship criteria include grade point average, financial need, extracurricular activities and community involvement.
MediEd: MediEd helps students prepare for careers in the life sciences industry by providing them with practical experience in key competencies for data management and informatics, study and site management, and ethical considerations for clinical trials. Medidata is donating its Rave EDC (electronic data capture) software to selected universities to capture, cleanse, and manage study data across every phase of the clinical trial life cycle. The partnership started with the University of North Carolina at Wilmington, and has now expanded to include Durham Technical Community College and Campbell University.
“At Medidata, we are committed to leveraging our expertise in life sciences and technology to have a positive impact on patients and students,” said Tarek Sherif, co-CEO and co-founder, Medidata. “These three programs exemplify our commitment to powering a future where everyone has access to treatment and education.”
Medidata is leading the digital transformation of life sciences, creating hope for millions of patients. Medidata helps generate the evidence and insights to help pharmaceutical, biotech, medical device and diagnostics companies, and academic researchers accelerate value, minimize risk, and optimize outcomes. More than one million registered users across 1,700+ customers and partners access the world's most trusted platform for clinical development, commercial, and real-world data. Medidata, a Dassault Systèmes company (Euronext Paris: FR0014003TT8, DSY.PA), is headquartered in New York City and has offices around the world to meet the needs of its customers. Discover more at www.medidata.com and follow us @Medidata,
Dassault Systèmes, the 3DEXPERIENCE® Company, is a catalyst for human progress. We provide business and people with collaborative virtual environments to imagine sustainable innovations. By creating virtual twin experiences of the real world with our 3DEXPERIENCE platform and applications, our customers can redefine the creation, production and life-cycle-management processes of their offer and thus have a meaningful impact to make the world more sustainable. The beauty of the Experience Economy is that it is a human-centered economy for the benefit of all – consumers, patients and citizens. Dassault Systèmes brings value to more than 300,000 customers of all sizes, in all industries, in more than 150 countries. For more information, visit https://www.3ds.com